Fulgent Genetics (FLGT) Equity Ratio (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Equity Ratio data on file, last reported at 0.9 in Q1 2026.

• Quarterly Equity Ratio fell 3.03% year-over-year to 0.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.9 (down 3.03% YoY) and the FY2025 annual result came in at 0.92, down 1.0% from the prior year.
• Equity Ratio slipped to 0.9 in Q1 2026 per FLGT's latest filing, from 0.92 in the prior quarter.
• The five-year high for Equity Ratio was 13.62 in Q4 2022, with the low at 0.9 in Q1 2022.
• Average Equity Ratio over 5 years is 1.66, with a median of 0.92 recorded in 2024.
• Year-over-year, Equity Ratio soared 1393.89% in 2022 and slumped 93.26% in 2023.
• Fulgent Genetics' Equity Ratio stood at 13.62 in 2022, then tumbled by 93.26% to 0.92 in 2023, then grew by 0.89% to 0.93 in 2024, then decreased by 1.0% to 0.92 in 2025, then fell by 1.46% to 0.9 in 2026.
• Business Quant data shows FLGT's Equity Ratio at 0.9 in Q1 2026, 0.92 in Q4 2025, and 0.92 in Q3 2025.